Module XVII - A Review of Animal Toxicology
INTRODUCTION
Welcome to the American Association of Poison
Control Center’s electronic continuing education program for Specialists
in Poison Information. This fourteen-day module will provide an introductory
review of animal toxicology.
release date - 5/8/99
most recent review date - 5/8//99
LEARNING OBJECTIVES
Upon completion of this electronic continuing education module, the participant will be able to:
1. Provide information concerning basic home management and criteria for referral of animals for emergency veterinary care after exposure to potentially toxic agents.
2. Identify species differences in response to common toxic exposures in animals.
3. Identify unique characteristics of the feline response to toxic insult.
4. List some basic similarities and differences
between human and veterinary toxicology.
AUTHOR
John Tegzes, VMD
REVIEW PANEL
Peter Ciancaglini, PharmD
Carl Hornfeldt, MS, RPh
Prashant Joshi, MD
Ruth Lawrence, MD
Fredrick Oehme, DVM, PhD
Christine Stork, PharmD
Paul Wax, MD
REFERENCES
1. Ettinger SJ, Ed. Textbook of Veterinary Internal Medicine, Philadelphia, WB Saunders, 1989.
2. Kirk RW, Ed. Current Veterinary Therapy XII, Philadelphia, WB Saunders, 1995.
3. Murtaugh RJ, Kaplan PM, Eds. Veterinary Emergency and Critical Care Medicine, St Louis, Mosby, 1992.
4. Sherding RG, Ed. The Cat, Disease and
Clinical Management, Philadelphia, WB Saunders, 1994
AUTHOR DECLARATION INFORMATION
As an accredited CME sponsor, the University of
Rochester Office of Continuing Professional Education requires that its
authors comply with ACCME Standards for Commercial Support of CME.
All authors are required to disclose any significant financial interest
or relationship that they may have with a supporting company or the manufacturer(s)
of any commercial product/service that will be discussed in the materials
they present.
ACCME STANDARDS OF COMMERCIAL SUPPORT OF CME
These standards require that materials be free
of commercial bias and that any information regarding commercial products/services
be based on scientific methods generally accepted by the medical community.
When discussing therapeutic options, it is our preference that only generic
names be used. If it is necessary to use a trade name, then those
of several companies must be used. Further, should the presentation
include discussion of any unlabelled or investigational use of a commercial
product, the author required to disclose this to the reader.
AUTHOR DECLARATIONS
NO DISCLOSURES have been made by the author(s)
of this module that could be perceived as a real or apparent conflict of
interest in the context of the subject of their presentation(s).
CERTIFICATION
The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The University of Rochester School of Medicine and Dentistry designates this educational activity for a maximum of 3.0 hours in Category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
This CME activity was planned and
produced in accordance with the Essentials and Standards of the Accreditation
Council for Continuing Medical Education.